Roche Holding AG Sustainability Profile
Roche Holding AG, commonly referred to as Roche, is a leading global healthcare company headquartered in Basel, Switzerland (CH). Founded in 1896, Roche has established itself as a pioneer in the pharmaceutical and diagnostics industries, focusing on innovative solutions for oncology, immunology, infectious diseases, and personalised medicine. With a strong presence in Europe, North America, and Asia, Roche is renowned for its commitment to research and development, producing unique products such as targeted therapies and advanced diagnostic tools. The company’s robust portfolio includes well-known medications like Herceptin and Avastin, which have transformed cancer treatment. Roche's dedication to innovation has earned it a prominent market position, consistently ranking among the top pharmaceutical companies globally. Its achievements in personalised healthcare and diagnostics underscore its role as a leader in advancing medical science and improving patient outcomes.
DitchCarbon Score
How does Roche Holding AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Roche Holding AG's score of 89 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Roche Holding AG's reported carbon emissions
In 2024, Roche Holding AG reported total greenhouse gas emissions of approximately 5,478,525,000 kg CO2e, comprising 245,832,000 kg CO2e from Scope 1, 69,198,000 kg CO2e from Scope 2, and 5,478,525,000 kg CO2e from Scope 3 emissions. In 2023, the total emissions were approximately 5,978,508,000 kg CO2e, with Scope 1 emissions at 240,266,000 kg CO2e, Scope 2 at 98,480,000 kg CO2e, and Scope 3 at 5,978,508,000 kg CO2e. Roche has set ambitious climate commitments, aiming for net-zero emissions across its entire value chain by 2045. The company has established near-term targets to reduce absolute Scope 1 and 2 emissions by 70% by 2029 from a 2022 baseline, and to cut Scope 3 emissions by 22.5% within the same timeframe. Additionally, Roche aims for a 90% reduction in absolute Scope 1, 2, and 3 emissions by 2045, also from a 2022 base year. These targets are aligned with the Science Based Targets initiative (SBTi) and reflect Roche's commitment to sustainable practices within the pharmaceutical industry. The company is actively working to ensure that 70% of its suppliers by emissions have science-based targets by 2029, further enhancing its sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 403,136,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 188,924,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Roche Holding AG's Industry?
How Carbon Intensive is Roche Holding AG's Location?
Roche Holding AG's Scope 3 Categories Breakdown
Roche Holding AG's Scope 3 emissions, which decreased by 8% last year and increased significantly since 2013, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.
Top Scope 3 Categories
Roche Holding AG's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Roche Holding AG has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Frequently Asked Questions
Common questions about Roche Holding AG's sustainability data and climate commitments
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.